New research suggests enhancing the brain’s own immune cells could help clear plaques associated with Alzheimer’s disease.

But he implied that only misguided contrarians could dispute that lecanemab established the amyloid hypothesis as fact, and that such drugs would illuminate the path to solve the Alzheimer’s puzzle.

“Matthew really opened up a new form of epigenetic inheritance,” says Dr. Brent Derry, Eroglu’s supervisor. “He found that amyloids can be inherited, marking a significant discovery in protein-based ...

For decades, scientists have focused on amyloid plaques—abnormal clumps of misfolded proteins that accumulate between neurons ...

Scientists have long been racking their brains for ways to treat Alzheimer’s disease, the most common type of dementia.

For more than three decades, scientists have been racing to stop Alzheimer's disease by removing amyloid beta plaques—sticky ...

Northwestern researchers made progress on new biochemical possibilities this week, in both the human brain and everyday ...